Sagae Y, Matsumoto Y, Unno K
J Pharmacobiodyn. 1983 Jul;6(7):475-80. doi: 10.1248/bpb1978.6.475.
The roles of the renin-angiotensin system (RAS) and aldosterone in the pathogenesis of nephrotic syndrome were investigated with rats following subcutaneous injections of puromycin aminonucleoside (PAN) for 7 d. Prominent reduction in plasma renin activity (PRA) was observed at day-15 after the initial treatment with PAN preceded by the onset of the nephrosis and there was no significant difference in plasma aldosterone concentration (PAC) between the nephrosis and normal control groups despite the higher levels obtained in the nephrosis animals. Although we could not elucidate the precise mechanism of reduction in PRA, it was suggested that neither the RAS nor aldosterone secretion played a primary role in the pathogenesis of the nephrosis. PAN-induced nephrosis is interesting in studying the pathophysiological mechanism of the lowered activity of plasma renin in some patients with nephrotic syndrome.
通过对大鼠皮下注射嘌呤霉素氨基核苷(PAN)7天,研究肾素-血管紧张素系统(RAS)和醛固酮在肾病综合征发病机制中的作用。在初次给予PAN治疗后第15天,在肾病发作之前观察到血浆肾素活性(PRA)显著降低,尽管肾病组动物的血浆醛固酮浓度(PAC)较高,但肾病组与正常对照组之间的血浆醛固酮浓度并无显著差异。虽然我们无法阐明PRA降低的确切机制,但提示RAS和醛固酮分泌在肾病发病机制中均未起主要作用。PAN诱导的肾病对于研究某些肾病综合征患者血浆肾素活性降低的病理生理机制具有重要意义。